Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCom.int.bk.regs Regulatory News (CBKD)

Share Price Information for Com.int.bk.regs (CBKD)

Share Price is delayed by 15 minutes
Get Live Data
2.45    -0.01 (-0.41%)
Bid:
2.425
Ask:
2.445
Spread: 0.02 (0.825%)
Market Cap: $8.08b
CBKD Live PriceLast checked at - London Stock Exchange

Intraday Com.int.bk.regs Share Chart

  • This share is an international stock.

CIB's 2011 Year-end Earning Release

23 Feb 2012 07:00

RNS Number : 9434X
Commercial Intnl Bank (Egypt) SAE
23 February 2012
Β 

CIB Shows Resilience And Maintains Its Leadership Position Within The Egyptian Banking Sector

CAIRO, February23rd, 2012 - Commercial International Bank (CIB), the leading financial institution in Egypt, today released its Year-End financial results.

Β 

2011 was a remarkable year for Egypt and CIB. The institution showed resilience, with trivial declines in top line numbers despite the challenges faced in 2011.

Business Highlights as of 31Β December 2011 - Consolidated Performance

β€’ On a consolidated basis, CIB achieved EGP 1,615 million in 2011 in comparison to EGP 2,021 million in December 2010, thus recording just 20% decline YoY primarily driven by much higher Provisions reaching EGP 321 million compared to just EGP 6 million in 2010as a pre-emptive measure to cope with the ongoing economic and political upheaval Egypt is witnessing.

β€’ Capital gains from sale of investments (Available for Sale and Held to Maturity portfolios as well as investment in associates) fell 80% to EGP 39 million in 2011 from EGP 203 million the previous year. In a strategic decision, the management saw fit not to sell investments at current market prices and, instead, hold them until prices reflect true values

β€’ In addition, a decline of almost 63% in Dividend income came on the back of the companies' decisions to retain their earnings after being affected by capital market activities in 2011 and adopting cash-preservation strategies.

β€’ Despite ongoing market challenges, CIB's gross loan growth stood at 16.93%, the bulk of which are LCY working capital facilities. Besides, deposits side grew by around 13% YoY.

β€’ Worth noting in this respect is that more than 50% of loan growth reported on a full-year basis was achieved in Q4'2011 standalone, reflecting that economic activity and confidence are improving.

β€’ CIB's loan market share recorded 8.66%, as of November, up from 8.01% in the beginning of the year. Market shares in deposits witnessed substantial growth as it recorded 7.23%as of November up from 6.70% in January.

β€’ Despite prevailing economic conditions, CIB maintained a healthy liquid LDR ratio of 60.1%.

β€’ CIB total assets grew by 13.40% compared to December 2010, largely due to the aforementioned loan growth.

β€’ On a standalone basis, Net Interest Margin YTD increased to reach 3.71% in 2011Β up from 3.62% in December 2010. This came as a result of both an increase in T-Bill rates (which prices-in gradually over time) and the focus on Egyptian pound lending versus FCY lending. It's worth noting that NIM has been increasing QoQ as it recorded 3.87% in Q4'2011 over 3.7% in Q3'2011.

β€’ CIB enjoys the lowest NPLs/Gross Loans among its peer group standing at 2.81% as of December 2011. Although the bank is growing its loan book, such growth clearly doesn't come at the expense of quality.

β€’ Coverage ratio remains healthy at 136.04% as of year-end 2011with minor decrease from 141.8% in December 2010.

β€’ ROAE and ROAA recorded 19.61% and 2.01% respectively.

β€’ 2011 witnessed almost flat consolidated revenues YoY, where December 2011's figure stood at EGP 3,929 million versus EGP 3,951 million in December 2010.

Key Operating Ratios - Consolidated

YTD

Dec-11

YTD

Dec-10

ROAA

Β 2.01%

2.89%

ROAE

19.61%

28.66%

Cost/Income

39.50%

39.52%

NIM*

3.71%

3.62%

*Calculated on a standalone basis to reflect core banking sustainable operations.

Summary Consolidated Income Statement

EGP Million

YTD

YTD

Variance

Dec-11

Dec-10

%

Net Interest Income

2,690

2,258

19.15%

Non Interest Income

1,244

1,694

-26.55%

Net Operating Income

3,934

3,952

-0.44%

Less:

Non Interest Expense

(1,557)

(1,562)

-0.28%

Provisions

(321)

(6)

5102.39%

Net Profit before Tax

2,056

2,384

-13.74%

Taxes

(442)

(362)

22.09%

Net Profit After Taxes

1,614

2,022

-20.17%

Minority Interest

(1)

1

-137.56%

Net Profit After Taxes

1,615

2,021

-20.09%

Β 

Revenues

β€’ Despite prevailing macro-picture in the country, management's priority was to focus on asset quality while growing the top line which remains resilient in CIB.

β€’ CIB's total consolidated revenues were almost flat on YoY basis. On quarterly basis, consolidated revenues in Q4'2011 recorded a good 17.8% growth over Q3'2011, while declined only by 4.7% below Q4'2010.

β€’ Such growth came on the back of a healthy rise in net interest income of 19.15%. In addition to a 13.2% increase in loan fees. The YoY 26.55% decline in non interest income is directly related to the slowdown in the sector due to the revolution.

β€’ Core banking fees witnessed a decrease of 1% to reach EGP 843 million, while other income from dividends and investment revaluations declined by 52% to EGP reach 401 million.

Β 

Expenses

β€’ On a Standalone basis, non interest expenses recorded 12.5% YoY increase driven mainly by increase in staff expenses which accounted for 25.4%. The reason behind this increase was decisions taken for the best interest of CIB's employees related to unified allowance as well as special increase in 2011based on the market.

β€’ Consolidated Cost: income ratio came in the same line with last year's and recorded 39.50% as of December 2011.

β€’ It is worth mentioning that the year 2011 had ended with cost: income ratio much less than what it began with, evidently, Q4'2011 recorded 38.52% down from 44.50% in Q1'2011. This reflects Management's strategic focus to keep the ratio below 40%.

Summary Consolidated Balance Sheet

EGP Million

Dec-11

Dec-10

Variance%

Cash and Due From Central Bank

7,492

5,675

32.01%

Due from Banks

8,528

7,055

20.89%

Gross Loans

42,933

36,717

15.28%

Provisions and Unearned items

(1,868)

(1542)

15.76%

Net Loans

41,065

35,175

16.75%

Treasuries & Investments

25,650

24,556

4%

Intangible Assets & Goodwill

430

537

-20%

Other Assets

2,369

2,427

-2.39%

Total Assets

85,534

75,425

13.40%

Due to Banks

3,341

1,322

152.67%

Customer Deposits

71,468

63,364

12.79%

Other Liabilities

1939

Β 2,125

-8.76%

Total Liabilities

76,748

66,812

14.87%

Equity

8,740

8,567

- 2.02%

Minority Interest

46

47

-1.30%

Β 

Credit Quality and Capital Adequacy

β€’ Well known for its conservative credit culture, management prudently took provisions of EGP 321 million YTD December 2011 in light of the current levels of uncertainty. This is up from EGP 6 million YTD December 2010.

β€’ Despite the current circumstances in the economy, CIB continues to maintain its resilient asset quality, with its NPLs/Gross loans relatively unchanged at 2.81%

β€’ CIB maintains its strong equity base with CAR of 13.78% compared to 14.41% in 2010 (both figures do not include profits of the year).

Β 

Β 

Β 

Β 

Β 

Β 

Stand-alone Performance

β€’ CIB ended the turbulent 2011 with EGP 1,749 million, only 18% down YoY on the back of the economic slowdown.

β€’ Total revenues are up by 2.96% YoY recording EGP 3,837 million as of December 2011 over EGP 3,727 millionΒ in December 2010. It's worth mentioning thatΒ Q4'2011 standalone recorded 14.1% growth over Q3'2011 and grew by 7.1% over Q4'2010.

β€’ Total assets grew by 14% YoY to record EGP 85,628 million as of year-end 2011.

β€’ CIB managed to realize ROAE of 21.0% and ROAA of 2.2% as of December2011.

β€’ Cost: income ratio stood at 34.84% up from 31.87% in December 2010 mainly due to the decline in income.

Summary Unconsolidated Income Statement

EGP Million

YTD

YTD

Variance

Dec-11

Dec-10

%

Net Interest Income

2,679

2,255

18.79%

Non Interest Income

1,159

1,472

-21.30%

Net Operating Income

3,837

3,727

2.96%

Non Interest Expense

(1,337)

(1,188)

12.52%

Provisions

(321)

(6)

5102.39%

Net Profit before Tax

2,180

2,533

-13.94%

Income Tax

(446)

(432)

3.40%

Deferred Tax

15

40

-61.15%

Net Profit

1,749

2,141

-18.32%

Summary Unconsolidated Balance Sheet

EGP Million

Dec-11

Dec-10

Variance %

Cash and Due From Central Bank

7,492

5,675

32.01%

Due from Banks

8,449

6,770

24.81%

Gross Loans

42,933

36,717

16.93%

Provisions and Unearned Items

(1868)

(1,542)

21.1

Net Loans

41,065

35,175

16.75%

Treasuries & Investments

26,358

25,273

4%

Other Assets

2,263

2,200

3%

Total Assets

85,628

75,093

14.03%

Due to Banks

3,341

1,322

152.65%

Customer Deposits

71,574

63,480

12.75%

Other Liabilities

1792

1682

6.55

Total Liabilities

76,707

66,484

15.38%

Equity

8,921

8,609

10.89%

Β 

Key Operating Ratios - Unconsolidated

Β 

YTD

Dec-11

YTD

Dec-10

NIM (%)

3.7

3.6

ROAA (%)

2.2

3.1

ROAE (%)

21.0

28.7

Cost/Income (%)

34.84%

31.87%

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
FR LLFVTFSIFFIF
Date   Source Headline
12th May 202610:18 amRNS1st Quarter Results
12th May 202610:16 amRNSCIB Consolidated Financial Statements 1Q26
12th May 202610:15 amRNS1Q26 Earnings Release
16th Mar 20267:00 amRNSResolutions Ordinary General Assembly March 2026
16th Mar 20267:00 amRNSResolutions Extraordinary GA March 2026
16th Mar 20267:00 amRNSResolutions Extraordinary GA March 2026
16th Mar 20267:00 amRNSResolutions Ordinary General Assembly March 2026
24th Feb 202612:31 pmRNSItems of Extraordinary GA
24th Feb 20267:00 amRNSPress Release dated 23th February 2026
19th Feb 20261:20 pmRNSItems of Extraordinary GA
19th Feb 20261:17 pmRNSInvitation to the Extraordinary GA 2026
19th Feb 20268:00 amRNSItems of OGA 2026
19th Feb 20268:00 amRNSInvitation to the OGA March 15
10th Feb 20267:00 amRNSCIB Summary of Board Resolution 9 Feb 2026
10th Feb 20267:00 amRNSFY25 Earnings Release
10th Feb 20267:00 amRNSCIB IFRS Consolidated Financial Statements FY25
15th Dec 20257:00 amRNSChange in Board of Directors
3rd Dec 20254:35 pmRNSCIB Bonus Shares Distribution 2025
4th Nov 20257:00 amRNSCIB Condensed Consolidated 3rd Quarter Results
4th Nov 20257:00 amRNSCIB 9M25 Earnings Release
4th Nov 20257:00 amRNS3rd Quarter Results
25th Sep 20253:55 pmRNSSummary of Resolutions - GAM September 2025
1st Sep 20257:02 amRNSInvitation to General Assembly September 2025
22nd Jul 20257:00 amRNSCIB 1H2025 Condensed Consolidated Financials
22nd Jul 20257:00 amRNSCIB 1H2025 Condensed Separate Financials
22nd Jul 20257:00 amRNS2Q25 Earnings Release
28th May 20256:00 pmRNSChanges to the Board of Directors
13th May 20257:00 amRNSSeparate- Q12025
13th May 20257:00 amRNS1Q25 Press Release
13th May 20257:00 amRNSConsolidated Financial Position at March 31.2025
24th Mar 20257:00 amRNSOrdinary General Assembly Resolutions Summary 2025
28th Feb 20257:00 amRNSGeneral Assembly 2025 - Discussion Items - amended
27th Feb 20257:47 amRNSInvitation to General Assembly 2025
27th Feb 20257:15 amRNSGeneral Assembly 2025 - Discussion Items
19th Feb 20257:00 amRNSCIB Annual Financial Report
19th Feb 20257:00 amRNSCIB FY2024 Earnings Release
6th Nov 20247:58 amRNSCIB gets regulatory approvals to changes to BoD
4th Nov 20247:00 amRNSEarnings Release 3Q.2024
4th Nov 20247:00 amRNSCIB-Separate Financial Statements 3Q.2024
4th Nov 20247:00 amRNSCIB-Consolidated Financial Statements 3Q.2024
1st Oct 20242:00 pmRNSCIB obtaining Long term loan from IFC
16th Sep 20248:00 amRNSChanges in CIB's Board of Directors
22nd Jul 20247:00 amRNSCIB H1-2024 Separate Financial Statements - E
22nd Jul 20247:00 amRNSH1.2024 Press Release
22nd Jul 20247:00 amRNSCIB H1-2024 Consolidated Financial Statements
13th May 20247:00 amRNS1st Quarter Results - Separate Statements
13th May 20247:00 amRNS1st Quarter Results - Consolidated Statements
26th Mar 20247:49 amRNSChanges in CIB's BOD - 25 March 2024
26th Mar 20247:00 amRNSOGM Resolutions - March 25th, 2024
26th Mar 20247:00 amRNSEGM Resolutions - March 25th, 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.